Patents by Inventor Meng Taing

Meng Taing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260153428
    Abstract: Described herein are systems and methods for sorting a cell in a fluidic device by immobilizing a cell of a plurality of cells and flowing a liquid through the fluidic device, wherein the liquid does not remove the immobilized cell from the fluidic device.
    Type: Application
    Filed: January 26, 2026
    Publication date: June 4, 2026
    Inventors: Tarun Kumar KHURANA, Meng TAING, Pier Federico GHERARDINI, Seyedsina MOEINZADEH, Vernon A. NORVIEL
  • Publication number: 20260125638
    Abstract: Disclosed herein are systems and methods for separating cells by selectively removing subpopulations of cells from fluidic devices. The methods can include synthesizing chambers that enclose a first subset of cells within a fluidic device and selectively removing a second subset of non-enclosed cells from the fluidic device.
    Type: Application
    Filed: October 31, 2025
    Publication date: May 7, 2026
    Inventors: Nirvan ROUZBEH, Elaheh FARJAMI, Meng TAING, Tarun KHURANA, Mostafa RONAGHI, Seyedsina MOEINZADEH
  • Patent number: 12600817
    Abstract: Systems for analyzing biological components are provided. The systems may include a fluidic device and an energy source in communication with the fluidic device. The energy source may supply energy to the fluidic device to form a polymer matrix on or adjacent to a biological component within the fluidic device. Methods of using the systems to analyze biological components are also provided.
    Type: Grant
    Filed: February 12, 2025
    Date of Patent: April 14, 2026
    Assignee: Cellanome, Inc.
    Inventors: Seyedsina Moeinzadeh, Justin Poelma, Meng Taing, Frank Charbonier, Tarun Kumar Khurana
  • Patent number: 12553819
    Abstract: Described herein are systems and methods for sorting and selecting cells by immobilizing or enclosing cells in degradable hydrogel chambers, including a method of sorting cells comprising: (a) providing a fluidics device comprising: (i) a channel comprising a surface, (ii) a spatial energy modulation element in optical communication with the surface, and (iii) a detector in optical communication with the surface and in operable association with the spatial energy modulating element, the detector identifying cells and determining positions thereof on the surface; (b) loading the channel with cells and one or more polymer precursors so that the cells are disposed on or adjacent to the surface; (c) immobilizing one or more cells selected based on one or more optical signals therefrom by synthesizing one or more gel structures enclosing each of the one or more cells by projecting light into the channel with the spatial energy modulating element such that the projected light causes cross-linking of the one or more
    Type: Grant
    Filed: December 9, 2024
    Date of Patent: February 17, 2026
    Inventors: Tarun Kumar Khurana, Meng Taing, Pier Federico Gherardini, Seyedsina Moeinzadeh
  • Publication number: 20250346950
    Abstract: The disclosure relates to tagged nucleoside compounds comprising a nucleotide polyphosphate covalentiy attached to a tag, wherein the compound is a polymerase substrate and the polymer moiety is capable of entering a nanopore linked to the polymerase and thereby altering the flow of ions through the nanopore. The disclosure also provides methods for preparing the tagged nucleoside compounds and for their use as tags in nanopore-based nucleic acid detection and sequencing.
    Type: Application
    Filed: March 13, 2025
    Publication date: November 13, 2025
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Frank Bergmann, Peter J. Crisalli, Sara Kelley, Omid Khakshoor, Hannes Kuchelmeister, Meng Taing
  • Publication number: 20250282912
    Abstract: Systems for analyzing biological components are provided. The systems may include a fluidic device and an energy source in communication with the fluidic device. The energy source may supply energy to the fluidic device to form a polymer matrix on or adjacent to a biological component within the fluidic device. Methods of using the systems to analyze biological components are also provided.
    Type: Application
    Filed: February 12, 2025
    Publication date: September 11, 2025
    Inventors: Seyedsina MOEINZADEH, Justin POELMA, Meng TAING, Frank CHARBONIER, Tarun Kumar KHURANA
  • Publication number: 20250283145
    Abstract: The invention includes improved methods and compositions for detecting methylation in nucleic acids. In particular, the disclosure is directed to methods of converting 5-hydroxymethylcytosine (5hmC) and/or 5-methylcytosine (5mC) to Thymine (T). In addition, the disclosure is also directed to methods of detecting 5hmC and/or 5mC in a sample.
    Type: Application
    Filed: February 8, 2022
    Publication date: September 11, 2025
    Inventors: Frank Bergmann, Shwu shin Chang, Peter Crisalli, Abre De Beer, Dieter Heindl, Omid Khakshoor, David Lawrence Penkler, Jo-Anne Elizabeth Penkler, Martin Ranik, Meng Taing
  • Patent number: 12270075
    Abstract: The disclosure relates to tagged nucleoside compounds comprising a nucleotide polyphosphate covalently attached to a tag, wherein the compound is a polymerase substrate and the polymer moiety is capable of entering a nanopore linked to the polymerase and thereby altering the flow of ions through the nanopore. The disclosure also provides methods for preparing the tagged nucleoside compounds and for their use as tags in nanopore-based nucleic acid detection and sequencing.
    Type: Grant
    Filed: August 25, 2020
    Date of Patent: April 8, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Frank Bergmann, Peter J. Crisalli, Sara Kelley, Omid Khakshoor, Hannes Kuchelmeister, Meng Taing
  • Publication number: 20250102419
    Abstract: Described herein are systems and methods for sorting and selecting cells by immobilizing or enclosing cells in degradable hydrogel chambers, including a method of sorting cells comprising: (a) providing a fluidics device comprising: (i) a channel comprising a surface, (ii) a spatial energy modulation element in optical communication with the surface, and (iii) a detector in optical communication with the surface and in operable association with the spatial energy modulating element, the detector identifying cells and determining positions thereof on the surface; (b) loading the channel with cells and one or more polymer precursors so that the cells are disposed on or adjacent to the surface; (c) immobilizing one or more cells selected based on one or more optical signals therefrom by synthesizing one or more gel structures enclosing each of the one or more cells by projecting light into the channel with the spatial energy modulating element such that the projected light causes cross-linking of the one or more
    Type: Application
    Filed: December 9, 2024
    Publication date: March 27, 2025
    Inventors: Tarun Kumar KHURANA, Meng TAING, Pier Federico GHERARDINI, Seyedsina MOEINZADEH
  • Publication number: 20240150824
    Abstract: The present disclosure relates to tagged nucleoside-5?-oligophosphates having a positively charged polymer tag structure and components thereof. Such nucleoside-5?-oligophosphates are useful, for example, in nanopore-based sequencing-by-synthesis applications. Also disclosed herein are nanopore constructs engineered to have additional negatively-charged moieties in the channel of the nanopore. Such nanopores can be useful, for example, for providing a repellant force against template and/or primer nucleic acids inserting into the pore during a nucleic sequence-by-synthesis process. The tagged nucleoside-5?-oligophosphates and nanopores disclosed herein can be used together to provide nanopore-based nucleic acid sequencing-by-synthesis systems and processes having reduced background tag levels and improved throughput.
    Type: Application
    Filed: August 9, 2021
    Publication date: May 9, 2024
    Inventors: Aruna Ayer, Frank Bergmann, Peter Crisalli, Lars Hillringhaus, Omid Khakshoor, Hannes Kuchelmeister, Rongxin Nie, Marshall W. Porter, Christoph Seidel, Seong-Ho Shin, Meng Taing, Adolfo Vargas
  • Publication number: 20240010668
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Application
    Filed: August 11, 2023
    Publication date: January 11, 2024
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Heindl, Omid Khakshoor, Meng Taing
  • Patent number: 11773130
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Grant
    Filed: July 6, 2022
    Date of Patent: October 3, 2023
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Heindl, Omid Khakshoor, Meng Taing
  • Publication number: 20230159999
    Abstract: This application discloses compositions comprising primer compounds that reduce or block deleterious threading into a nanopore of nucleic acid strands displaced by a nanopore-linked polymerase, for example during the use of a nanopore device for nucleic acid sequencing. Also disclosed are methods for using the compositions to reduce deleterious threading events during nanopore-based nucleic acid detection techniques, such as nanopore sequencing.
    Type: Application
    Filed: August 4, 2022
    Publication date: May 25, 2023
    Inventors: Aruna Ayer, David Beyer, Peter Crisalli, Kirti Dhiman, Helen Franklin, Swathi Chakravarthy, Omid Khakshoor, Blake Langdon, Meng Taing, Adolfo Vargas
  • Publication number: 20220348604
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Application
    Filed: July 6, 2022
    Publication date: November 3, 2022
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Hiendl, Omid Khakshoor, Meng Taing
  • Patent number: 11440933
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: September 13, 2022
    Assignee: ROCHE SEQUENCING SOLUTIONS, INC.
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Hiendl, Omid Khakshoor, Meng Taing
  • Publication number: 20220041642
    Abstract: The present disclosure provides 3? protected nucleotides, including those 3? protected nucleotides having a detectable tag. Systems and methods of sequencing nucleic acids using the 3? protected nucleotides are also disclosed, such as the sequencing of a nucleic acid using a nanopore or the sequencing of a nucleic acid via sequencing-by-synthesis.
    Type: Application
    Filed: December 16, 2019
    Publication date: February 10, 2022
    Inventors: Frank Bergmann, Peter Crisalli, Dieter Hiendl, Omid Khakshoor, Meng Taing
  • Publication number: 20210292832
    Abstract: The present disclosure relates to tagged multi-nucleotide compounds, which comprise a single tag moiety covalently linked to a plurality of nucleoside-5?-oligophosphate moieties. As disclosed herein, these tagged multi-nucleotide compounds have improved characteristics as polymerase substrates and can be used in a range of nucleic acid detection and sequencing methods, including nanopore sequencing-by-synthesis.
    Type: Application
    Filed: February 22, 2021
    Publication date: September 23, 2021
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Dmitriy Gremyachinskiy, Meng Taing, Aruna Ayer, Peter J. Crisalli
  • Patent number: 10975432
    Abstract: The present disclosure relates to tagged multi-nucleotide compounds, which comprise a single tag moiety covalently linked to a plurality of nucleoside-5?-oligophosphate moieties. As disclosed herein, these tagged multi-nucleotide compounds have improved characteristics as polymerase substrates and can be used in a range of nucleic acid detection and sequencing methods, including nanopore sequencing-by-synthesis.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: April 13, 2021
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Dmitriy Gremyachinskiy, Meng Taing, Aruna Ayer, Peter J. Crisalli
  • Publication number: 20200385803
    Abstract: The disclosure relates to tagged nucleoside compounds comprising a nucleotide polyphosphate covalently attached to a tag, wherein the compound is a polymerase substrate and the polymer moiety is capable of entering a nanopore linked to the polymerase and thereby altering the flow of ions through the nanopore. The disclosure also provides methods for preparing the tagged nucleoside compounds and for their use as tags in nanopore-based nucleic acid detection and sequencing.
    Type: Application
    Filed: August 25, 2020
    Publication date: December 10, 2020
    Inventors: Frank Bergmann, Peter J. Crisalli, Sara Kelley, Omid Khakshoor, Hannes Kuchelmeister, Meng Taing
  • Publication number: 20200263248
    Abstract: The present disclosure relates to tagged multi-nucleotide compounds, which comprise a single tag moiety covalently linked to a plurality of nucleoside-5?-oligophosphate moieties. As disclosed herein, these tagged multi-nucleotide compounds have improved characteristics as polymerase substrates and can be used in a range of nucleic acid detection and sequencing methods, including nanopore sequencing-by-synthesis.
    Type: Application
    Filed: March 18, 2020
    Publication date: August 20, 2020
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Dmitriy Gremyachinskiy, Meng Taing, Aruna Ayer, Peter J. Crisalli